Exhibit 99.7

UCB US Twitter post:For Media: UCB has entered into a definitive agreement to acquire @Zogenix. This broadens and builds upon UCBs role as a leader in, and our continued commitment to, addressing the unmet needs of people living with #epilepsy. #DravetSyndrome #Dravet https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/ucb-acquire-zogenixUCB US@UCBUSAFor Media: UCB has entered into a definitive agreement to acquire @Zogenix. This broadens and builds upon UCBs role as a leader in, and our continued commitment to, addressing the unmet needs of people living with #epilepsy. #DravetSyndrome #DravetUcb Inspired by patients.Driven by science.Ucb-usa.comRead more7:00 AM Jan 19, 2022 Twitter for Advertisers

UCB News Twitter post:For media. Today we announced our entry into a definitive agreement to acquire Zogenix, a global biopharmaceutical company commercializing and developing rare epilepsy therapies. Learn more:https://https://t.co/2quQR787KWUCB News@ucb_newsFor media. Today we announced our entry into a definitive agreement to acquire Zogenix, a global biopharmaceutical company commercializing and developing rare epilepsy therapies. Learn more:ucb.com/stories-media/&Ucb Inspired by patients.Driven by science.1:16 Am Jan 19, 2022 Twitter Web App